Background <p>Prostate cancer (PCa) is a prevalent malignancy in men, with exosomes playing a key role in tumor microenvironment and disease progression, yet their molecular mechanisms remain unclear.This study aims to identify potential biomarkers and therapeutic targets in PCa by integrating exosome-related genes with differentially expressed genes (DEGs).</p> Methods <p>Four GEO datasets (GSE32448, GSE46602, GSE69223, GSE6956) were analyzed. Batch effects were corrected using the ComBat method, followed by DEG analysis and feature selection via machine learning (LASSO regression, random forest, SVM). Functional enrichment and molecular docking validated the findings.</p> Results <p>Post-correction, sample clustering improved significantly. Of 49 overlapping DEGs and exosome-related genes, EEF2, LGALS3, and MYO1D emerged as key biomarkers, with EEF2 showing the highest predictive power (AUC = 0.786). A risk score model achieved an AUC of 0.886. Immune analysis linked these genes to immune cell subsets, and docking studies revealed strong interactions with small molecules like cycloheximide.</p> Conclusion <p>This study elucidates the molecular role of exosome-related genes in PCa, proposing predictive biomarkers and novel therapeutic targets, warranting further clinical validation.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Integration of exosome-related genes and differential expression analysis reveals potential biomarkers for prostate cancer

  • Shengnan Huang,
  • Chunyan Hu,
  • Zhongqi Guo,
  • Xiaojing Zhang,
  • Tiantian Wu,
  • Yuqing Zeng,
  • Chen Qing,
  • Shulin Cheng

摘要

Background

Prostate cancer (PCa) is a prevalent malignancy in men, with exosomes playing a key role in tumor microenvironment and disease progression, yet their molecular mechanisms remain unclear.This study aims to identify potential biomarkers and therapeutic targets in PCa by integrating exosome-related genes with differentially expressed genes (DEGs).

Methods

Four GEO datasets (GSE32448, GSE46602, GSE69223, GSE6956) were analyzed. Batch effects were corrected using the ComBat method, followed by DEG analysis and feature selection via machine learning (LASSO regression, random forest, SVM). Functional enrichment and molecular docking validated the findings.

Results

Post-correction, sample clustering improved significantly. Of 49 overlapping DEGs and exosome-related genes, EEF2, LGALS3, and MYO1D emerged as key biomarkers, with EEF2 showing the highest predictive power (AUC = 0.786). A risk score model achieved an AUC of 0.886. Immune analysis linked these genes to immune cell subsets, and docking studies revealed strong interactions with small molecules like cycloheximide.

Conclusion

This study elucidates the molecular role of exosome-related genes in PCa, proposing predictive biomarkers and novel therapeutic targets, warranting further clinical validation.